| NevGold Intercepts 1.11% Antimony Over 6.1 Meters, Within 1.93 g/t AuEq Over 100.6 Meters (1.07 g/t Au And 0.22% Antimony) From Surface; Focus On Maiden Antimony-Gold Mineral Resource Estimate and Near-Term Antimony Production |
Globe Newswire |
04/09 |
07:45 |
| Data Centre LIVE debuts in London with sector-leading speakers |
Globe Newswire |
04/09 |
07:41 |
| Entrée Resources Provides JV Licenses Update and Drill and Regional Exploration Results |
Globe Newswire |
04/09 |
07:37 |
| Shareholders who lost money in Medpace Holdings, Inc. (NASDAQ: MEDP) Should Contact Wolf Haldenstein Immediately |
Globe Newswire |
04/09 |
07:30 |
| Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline |
Globe Newswire |
04/09 |
07:30 |
| AGA Precision Systems Signs Second Long-Term Supply Agreement to Manufacture Aerospace and Defense Components for a Tier 1 Firm |
Globe Newswire |
04/09 |
07:30 |
| Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026 |
Globe Newswire |
04/09 |
07:30 |
| Greenlane Holdings Provides Digital Asset Treasury Update and Announces $2.0 Million Share Repurchase Program |
Globe Newswire |
04/09 |
07:30 |
| Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,* |
Globe Newswire |
04/09 |
07:30 |
| Weight Watchers Announces Board Committee Appointments |
Globe Newswire |
04/09 |
07:30 |
| Exodus Launches Exodus Pay to Let Users Spend, Send, and Earn Rewards from One App |
Globe Newswire |
04/09 |
07:25 |
| Shareholders who lost money in Vital Farms, Inc. (NASDAQ: VITL) Should Contact Wolf Haldenstein Immediately |
Globe Newswire |
04/09 |
07:19 |
| Shareholders who lost money in Gossamer Bio, Inc (NASDAQ: GOSS) Should Contact Wolf Haldenstein Immediately |
Globe Newswire |
04/09 |
07:11 |
| New Era Energy & Digital Announces Pricing of $100 Million Public Offering of Common Stock |
Globe Newswire |
04/09 |
07:02 |
| Sigma Automate Emerges from Stealth with $2.75M in Funding to Close the Enterprise IT Automation Gap |
Globe Newswire |
04/09 |
07:00 |
| ScottsMiracle-Gro Completes Divestiture of Hawthorne Subsidiary |
Globe Newswire |
04/09 |
07:00 |
| The Simply Good Foods Company Reports Fiscal Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Outlook |
Globe Newswire |
04/09 |
07:00 |
| Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting |
Globe Newswire |
04/09 |
07:00 |
| How AI-Native Deal Intelligence Is Changing Private Company Research |
Globe Newswire |
04/09 |
07:00 |
| Aurora Mobile Debuts Modellix: A Unified Gateway for Next-Gen AI Media Generation |
Globe Newswire |
04/09 |
07:00 |
| How AI Search Is Reshaping How Traders Vet Online Brokers |
Globe Newswire |
04/09 |
07:00 |
| Rubicon Organics to Present at International Cannabis Conferences in April 2026 |
Globe Newswire |
04/09 |
07:00 |
| Capstreet-backed TradePending Announces Executive Appointments |
Globe Newswire |
04/09 |
07:00 |
| Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate |
Globe Newswire |
04/09 |
07:00 |
| C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs) |
Globe Newswire |
04/09 |
06:59 |
